vimarsana.com
Home
Live Updates
Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague : vimarsana.com
Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague
/PRNewswire/ -- Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the...
Related Keywords
Copenhagen
,
Køavn
,
Denmark
,
Prague
,
Praha
,
Hlavníesto
,
Czech Republic
,
Aleena Azam
,
Ulrich Krasilnikoff
,
World Molecular Imaging Congress
,
University Of Copenhagen
,
Primary Gliomas
,
Prognostic Value
,
Targeted Radionuclide
,
Molecular Imaging
,
Springer Publisher
,
Positron Emissions Tomography
,
Radionuclide Therapy
,
Curasight
,
vimarsana.com © 2020. All Rights Reserved.